# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Alstrom syndrome

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
Status: Active, not recruiting
Last Changed: May 17, 2019
First Received: Jun 12, 2017
Disease(s): Alström Syndrome
Intervention(s): PBI-4050
Locations: University Hospitals Birmingham NHS Foundation Trus, Birmingham, United Kingdom
Clinical Study of a Single Ciliopathy: Alström Syndrome
Status: Terminated
Last Changed: Jun 21, 2019
First Received: Sep 07, 2016
Disease(s): Alström Syndrome (ALMS)
Locations: CMCO, Hôpitaux Universitaires, Schiltigheim, France
Centre d'Investigation Clinique, Nouvel Hôpital Civil, Hôpitaux Universitaires, Strasbourg, France
Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), Hôpitaux Universitaires, Strasbourg, France
Clinique Psychiatrique, Hôpital Civil, Hôpitaux Universitaires, Strasbourg, France
Service de Cardiologie, Nouvel Hôpital Civil, Hôpitaux Universitaires, Strasbourg, France
... and 10 other locations.
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Nov 19, 2018
Disease(s): Bardet Biedl Syndrome (BBS), Alström Syndrome (AS)
Intervention(s): Setmelanotide, Placebos
Locations: Wr-McCr, Llc, San Diego, California, United States
UMMS Baystate Health; BAYSTATE MEDICAL CENTER; Baystate Children's Specialty Center, Springfield, Massachusetts, United States
Columbia University Center, New York, New York, United States
M3 Wake Research, Raleigh, North Carolina, United States
University of Tennessee Health Science Center, Memphis, Tennessee, United States
... and 9 other locations.
Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome
Status: Completed
Last Changed: Aug 29, 2018
First Received: Apr 15, 2016
Disease(s): Inflammation and Fibrosis, Diabetes
Intervention(s): PBI-4050
Locations: University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Jan 06, 2017
Disease(s): Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Bardet-Biedl Syndrome, Alstrom Syndrome, Smith-Magenis Syndrome
Intervention(s): Setmelanotide
Locations: Honor Health Research Institute, Scottsdale, Arizona, United States
Axis Clinical Trials Headquarters, Los Angeles, California, United States
Axis Clinical Trials-Downtown, Los Angeles, California, United States
University of Colorado Hospital, Aurora, Colorado, United States
University of Florida College of Medicine, Gainesville, Florida, United States
... and 19 other locations.